
Accelerating success through strategic alliances.
An ambitious collaboration between Alliance for Cancer Gene Therapy, Cancer Research Institute and Parker Institute for Cancer Immunotherapy is tackling the challenges of the deadliest brain cancer in adults – glioblastoma multiforme (GBM) – and accelerating cellular therapies to battle this complex disease.

Bringing together the experts who are changing the future of cancer.
From frontline cancer researchers at prestigious institutions to visionary icons of philanthropy and business, ACGT is bringing together today’s most accomplished professionals as they explore the future of cancer cell and gene therapies at Alliance for Cancer Gene Therapy Summit and Awards Luncheon on March 30.